BROKERS CHOICE: BSE, MAXHOSPITAL, BIOCON, MGL, PFC, REC, HCLTECH

AHMEDABAD, 14 JANUARY: અગ્રણી બ્રોકરેજ હાઉસ તથા ફંડ હાઉસ તરફથી પસંદગીના સ્ટોક્સમાં ખરીદી\ વેચાણ\ હોલ્ડ કરવા માટે ભલામણ કરવામાં આવી છે. તે રોકાણકારોના અભ્યાસ માટે અત્રે રજૂ કરીએ છીએ.

Jefferies on BSE: Upgrade to Hold on Company, raise target price at Rs 5250/Sh (Positive)

Jefferies on Max Hospitals: Maintain Buy on Company, raise target price at Rs 1380/Sh (Positive)

HSBC on Biocon: Upgrade to Buy on Company, raise target price at Rs 430/Sh (Positive)

MS on MGL: Maintain Overweight on Company, target price at Rs 1606/Sh (Positive)

ICICI on PFC: Initiate Buy on Company, target price at Rs 550/Sh (Positive)

ICICI on REC: Initiate Buy on Company, target price at Rs 600/Sh (Positive)

Nuvama on Jindal Stainless: Upgrades to Buy on Company, target price at Rs 836/Sh (Positive)

Jefferies on Hospitals: Max Healthcare and Fortis are top picks among the sector. (Positive)

Macquarie on United Spirits: Maintain Underperform on Company, target price at Rs 1175/Sh (Neutral)

Jefferies on HCL Tech: Maintain Hold on Company, target price at Rs 2060/Sh (Neutral)

Nomura on HCL Tech: Maintain Buy on Company, target price at Rs 2000/Sh (Neutral)

Citi on HCL Tech: Maintain Neutral on Company, target price at Rs 1920/Sh (Neutral)

CLSA on HCL Tech: Maintain Hold on Company, target price at Rs 1882/Sh (Neutral)

Bernstein on HCL Tech: Maintain Market Perform on Company, target price at Rs 2000/Sh (Neutral)

MS on HCL Tech: Maintain Equal weight on Company, target price at Rs 1970/Sh (Neutral)

Nuvama on HCL Tech: Downgrade to Hold on Company, raise target price at Rs 2150/Sh from Rs 2125/Sh (Neutral)

(Disclaimer: The information provided here is investment advice only. Investing in the markets is subject to risks and please consult your advisor before investing.)

(સ્પષ્ટતા: અત્રેથી આપવામાં આવતી તમામ પ્રકારની માહિતી કોઇપણ પ્રકારે રોકાણ/ ટ્રેડીંગ માટેની સલાહ નથી. બજારોમાં રોકાણ જોખમોને આધીન છે અને રોકાણ કરતા પહેલા કૃપા કરીને તમારા સલાહકારની સલાહ લો.)